Irbesartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 63187-981
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 63187-981). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1b (Image 02)
Image02a (Image 03)
Image02b (Image 04)
Irbesartan Chemical Structure (Image 05)
Hctz Chemical Structure (Image 06)
Figure03 (Image 07)
Figure04 (Image 08)
63187-981-30 (Image 09)
This is a medication description for Irbesartan 150mg/Hydrochlorothiazide 12.5mg tablets. The tablets are light pink to pink, capsule-shaped, and film-coated, with "TEVA" and "7238" inscribed on either side. The medication is manufactured in Israel by Teva Pharmaceutical Industries Ltd. and distributed in the US by Proficient Rx LP. The medication is only available via prescription, with each tablet containing 150mg of Irbesartan USP and 12.5mg of Hydrochlorothiazide USP. It has an NDC number of 63187-981-30, a product ID of R1098130, and is presented in a pack of 30 tablets. The medication should be kept out of reach of children and stored at room temperature between 20°C and 25°C (68°F and 77°F).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.